FindTrial
Sign In

Determination of risk factors for internal mammary lymph node recurrence in breast cancer patients

Determination of risk factors for internal mammary lymph node recurrence in breast cancer patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500106308
Enrollment
Unknown
Registered
2025-07-22
Start date
2025-08-01
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

Breast cancer patients undergoing postoperative adjuvant radiotherapy group:None

Sponsors

The Second Affiliated hospital of Fujian Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1.Confirmed diagnosis of breast malignancy; 2.Patients who completed postoperative adjuvant radiotherapy at our hospital between 2018 and 2024 with complete radiotherapy records; 3.Patients with complete follow-up data or accessible for telephone follow-up;

Exclusion criteria

Exclusion criteria: 1.No follow-up data available; 2.Incomplete postoperative adjuvant radiotherapy at our hospital;

Design outcomes

Primary

MeasureTime frame
Internal mammary lymph node recurrence-free survival (IMLN-RFS);—

Countries

China

Contacts

Public ContactYanhong Wang

The Second Affiliated hospital of Fujian Medical University

992415639@qq.com+86 595 26655105

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026